-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Scientists at Baylor College of Medicine, Texas Children's Hospital and partner institutions said they have found that genetic variants associated with Alzheimer’s risk can disrupt The protective mechanism of the brain, which leads to neurodegeneration
In this study, “the formation of glial lipid droplets induced by neuron ros was altered by the loss of Alzheimer’s disease-related genes,” an article published in the Proceedings of the National Academy of Sciences (PNAS) also revealed The evidence supports reactive oxygen species (ROS), which is a natural by-product of cell metabolism, is related to inflammation and other processes, and is a key factor leading to the destruction of neuroprotective mechanisms
In short, these findings seem to provide a new mechanism for the development of Alzheimer's disease and support the idea that multiple changes at the genetic and other cellular levels combine to induce disease
More and more genetic risk factors for Alzheimer's disease (AD) are being identified, but the contribution of each variant to the disease mechanism is still largely unknown
"In order to determine the proteins that regulate these neuroprotective effects, we tested the role of AD risk genes in the formation of ros-induced LD, and proved that several genes affect the formation of neuroprotective LD, including human ABCA1, ABCA7, VLDLR, VPS26, Homologs of VPS35, AP2A, PICALM and CD2AP
"Finally, the peptide agonist of ABCA1 can restore the formation of glial LD in the humanized APOE4 Drosophila model, which provides a potential therapeutic approach to prevent ros-induced neurotoxicity
"Previous work by Dr.
When neurons are faced with high levels of ROS, neuroprotective mechanisms come into play, stimulating neurons to produce rich lipids
In previous studies, the researchers linked the neuroprotective mechanism to the strongest genetic risk factor for Alzheimer's disease, the apolipoprotein APOE4
Moulton pointed out: "In our current work, we want to identify genes that are essential for lipid droplet formation, especially those that are required for the export of lipids from neurons and the introduction of lipids into glial